Stock Analiz

aTYR PHARMA INC (ATYR) stock forecast and price target

Price $6.11 · data as of November 13, 2026

12-month price target

Average target$45.17
Upside / downside+639.8%
Analysts6
ConsensusHold
Low $5.00Average $45.17High $160.00

Gold marker: average target · white marker: today’s price ($6.11)

Analyst ratings

Strong buy 2Buy 1Hold 6Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-23.97+22.9%$0
Next fiscal year
ends December 31, 2027
$-114.76−426.4%$0
Next quarter
ends December 31, 2026
$-39.16−706.4%$0
Quarter after
ends March 31, 2027
$-74.50−2411.8%$0

Consensus of the analysts covering aTYR PHARMA INC, updated daily. In the last 30 days 2 estimates were raised and 1 lowered.

Frequently asked questions

What is the aTYR PHARMA INC stock price target?

The average 12-month target from 6 analysts is $45.17, 639.8% above the current price of $6.11 Targets range from $5.00 to $160.00.

Is aTYR PHARMA INC a buy according to analysts?

The consensus rating is “Hold” (2 strong buy, 1 buy, 6 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is aTYR PHARMA INC expected to earn?

Analysts expect EPS of $-23.97 for the fiscal year ending December 31, 2026 and $-114.76 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.